Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advisory committee schedule

This article was originally published in The Tan Sheet

Executive Summary

CFSAN's Food Advisory Committee (FAC) Infant Formula Subcommittee has tentative plans to convene in August 2005, according to an announcement slated to appear in an upcoming issue of the Federal Register. Next year's dates for the FAC Dietary Supplements and Nutrition subcommittees and parent committee have yet to be determined. CDER's Nonprescription Drugs Advisory Committee is set to meet jointly with Endocrinologic & Metabolic Drugs Jan. 13-14 to discuss OTC status for Merck's Mevacor, and will then convene March 23-25 with the Dermatologic & Ophthalmic Drugs committee...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS097634

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel